Pfizer, Antares Pharma partner on opioid overdose pen

Aug 06, 2018

Pfizer and Antares Pharma have announced an agreement to develop a combination drug device opioid overdose “rescue pen.”

The rescue pen will utilize the Antares QuickShot auto injector and an undisclosed Pfizer drug.

Under the terms of the agreement, Pfizer will pay for the development of the product and will be responsible for obtaining FDA approval of the combination product. Antares will provide fully packaged commercial ready finished product to Pfizer at cost plus margin and Pfizer will then be responsible for commercializing the product in the United States, pending FDA approval.

Read the press release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments